> Herbal supplement supplier American Oriental Bioengineering is buying China's Guangxi Lingfeng Pharmaceutical for $25 million. Guangxi Lingfeng earned about $10 million last year from its sale of plant-based medicines. Report
> CombinatoRx says that a mid-stage trial for CRx-170 for asthma demonstrated promising results. Report
> An investment bank estimates that India's growing biotech industry will pass $5 billion in revenue by 2010. At that point, India should have one million people employed in biotechnology as more products are produced, more partnering occurs on a worldwide basis, more clinical trials are hosted and bio-generics gain acceptance. "With ample opportunities available to be capitalized on without compromising on quality," India seems like the ideal low-cost destination, the report says. Report
> TheraQuest announced that the FDA has fast-tracked Tramadol ER. Report
> Mylan Laboratories says that the FDA has approved its generic copy of Merck's Proscar. Report
> Canada's Chemokine Therapeutics has reacquired the licensing rights to CTCE-0214 from Pharmaceutical Product Development. Release
> Neurochem's NDA for eprodisate (Fibrillex) has been granted a priority review by the FDA. Release
> ArQule has received a milestone payment from Wyeth for a compound under development for Alzheimer's. Release
And Finally... Exposing mushrooms to UV light can quickly make it an unlikely source of vitamin D. Article